Unique ID issued by UMIN | UMIN000022385 |
---|---|
Receipt number | R000025797 |
Scientific Title | The effect of exercise and L-citrulline and L-leucine supplementation on vital function in elderly sarcopenic people.:Placebo-controlled, double-blind, parallel design trial |
Date of disclosure of the study information | 2017/12/30 |
Last modified on | 2021/02/16 14:03:49 |
The effect of exercise and L-citrulline and L-leucine supplementation on vital function in elderly sarcopenic people.:Placebo-controlled, double-blind, parallel design trial
The effect of amino acids on vital function.
The effect of exercise and L-citrulline and L-leucine supplementation on vital function in elderly sarcopenic people.:Placebo-controlled, double-blind, parallel design trial
The effect of amino acids on vital function.
Japan |
Healthy volunteers
Adult |
Others
NO
The aim of this study is to investigate the effect of exercise and L-citrulline and L-leucine supplementation on vital function in elderly sarcopenic people.
Safety,Efficacy
Confirmatory
Pragmatic
Not applicable
Physical strength(0,12,20 weeks)
questionnaire
Blood analysis
Cfpwv
Five Cognitive Functions
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Prevention
Food |
Light exercise and intake of placebo for 20 weeks.
Light exercise and intake of amino acids for 20 weeks.
65 | years-old | <= |
80 | years-old | >= |
Female
(1)women from 65 to 80 years of age
(2)16 to 21 of BMI
(3)It is applicable to more than one item of physical ability in basic health check list for those over 65years old
(4)Subject who usually doesn`t exercise
(5)Subject who has exercise contraindication
(6)Subject has given consent to participate in the study
(7)Subject who gets motivated to this study
(8)Subject has given consent to participate continuously once per 1week
(1)Subject is taking a neurological medicine
(2) Subjects having a current or past history of serious diseases such as diabetes, hepatic or renal disorder, or cardiovascular disease
(3)a drinking habit
(4) Subjects having possibilities for emerging allergy related to the study
(5)a smoking habit
(6) Subjects who have done hematologic test within the last 10 weeks prior
(7) Subjects who have participated in other clinical study within the last 10 weeks prior to the current study or are participating in other clinical study currently
(8) Subjects judged as unsuitable for the study by the investigator for other reasons
40
1st name | |
Middle name | |
Last name | Okura Tomohiro |
University of Tsukuba
Faculty of Health and sport science
1-1-1 Tennodai, Tsukuba
029-859-2733
okura@taiiku.tsukuba.ac.jp
1st name | |
Middle name | |
Last name | Yoon Jiyeong |
University of Tsukuba
Faculty of Health and sport science
1-2 Kasuga, Tsukuba
029-859-1593
yoon.jiyeong.fw@u.tsukuba.ac.jp
Tsukuba University
KYOWA HAKKO BIO CO., LTD.
Profit organization
NO
2017 | Year | 12 | Month | 30 | Day |
Unpublished
Preinitiation
2016 | Year | 03 | Month | 31 | Day |
2016 | Year | 06 | Month | 06 | Day |
2016 | Year | 12 | Month | 31 | Day |
2016 | Year | 05 | Month | 20 | Day |
2021 | Year | 02 | Month | 16 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025797